MAPT and tauopathy: In a mouse model of tauopathy, activation of PKA early in the disease was shown to be beneficial in attenuating Tau-driven proteasome dysfunction, leading to lower levels of aggregated Tau and improved cognitive performance [237,238], underlying the fundamental role of PKA in phosphorylating proteasome subunits.